NR3C1 and type 2 diabetes mellitus: Other positive correlation, T2D-AD associated drugs included budesonide (corticosteroid for Crohn’s disease) and mometasone (steroid for skin discomfort), both of which are glucocorticoid receptor agonists with the target of NR3C1.